Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (SEK)302.30
  • Today's Change0.300 / 0.10%
  • Shares traded174.89k
  • 1 Year change+18.32%
  • Beta0.2598
Data delayed at least 15 minutes, as of Nov 05 2024 13:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.

  • Revenue in SEK (TTM)124.52bn
  • Net income in SEK11.81bn
  • Incorporated1988
  • Employees36.01k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Essity AB (publ)124.52bn11.81bn212.11bn36.01k17.952.5312.041.7016.8329.69177.44119.410.63493.725.053,457,529.005.995.078.647.4934.8929.419.447.080.954310.300.36258.9712.054.4384.743.66-0.16276.15
Galderma Group AG46.29bn-152.24m240.04bn6.55k--2.9581.925.19-0.0517-0.051715.7027.76------569,949.60--------69.54---0.3266--0.92061.200.2786--7.65--40.97------
Beiersdorf AG112.98bn8.61bn362.17bn22.49k38.443.3429.293.213.263.2642.7137.470.7382.694.45441,114.805.716.388.288.9558.1457.237.748.601.34--0.062225.337.365.49-2.520.21887.637.39
Reckitt Benckiser Group Plc199.08bn21.45bn473.13bn40.00k22.794.2816.842.382.172.1720.0711.540.53143.496.58358,200.005.751.548.252.1060.5659.3210.813.370.469218.660.5237283.981.073.01-30.08-5.480.54332.43
Data as of Nov 05 2024. Currency figures normalised to Essity AB (publ)'s reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.